Read full articleACCESSWIRECore One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer’s and Parkinson's DiseaseCore One Labs Inc.Fri, Aug 4, 2023, 7:25 PMLink Copied0In this article: